文献速递特殊人群用药药物不良反应与药物警戒

1997-2018年美国妊娠早期处方药使用模式

Patterns of Prescription Medication Use during the First Trimester of Pregnancy in the United States, 1997-2018.
PubMed 文献 · Clin Pharmacol Ther · 2023-07-11

该研究基于两项美国大型病例对照研究中9755名对照产妇数据,描述1997-2011年及2014-2018年妊娠早期处方药使用模式。妊娠早期至少使用一种处方药的比例从37%升至50%,止吐药使用相对增幅最大(3.8%至14.8%),主要由昂丹司琼驱动。

要点

  • 妊娠早期处方药使用普遍且逐年增加,从37%升至50%。
  • 止吐药使用相对增幅最大,从3.8%升至14.8%,主要由昂丹司琼驱动。
  • 用药比例随母亲年龄和受教育年限增加,非西班牙裔白人最高(47%),西班牙裔最低(24%)。

核心结论

  • 妊娠早期处方药使用常见且呈增加趋势,许多疾病需要药物治疗,须权衡母胎风险与安全。

研究设计与样本

  • 描述性二次分析,数据来自1997-2011年和2014-2018年两项美国大型病例对照研究中9755名对照产妇。
  • 排除维生素、草药、矿物质、疫苗、静脉输液、局部产品和非处方药。

主要发现

  • 妊娠早期至少使用一种处方药的比例从37%升至50%。
  • 用药比例随母亲年龄和受教育年限增加,非西班牙裔白人最高(47%),西班牙裔最低(24%)。
  • 妊娠早期用药最常见指征为感染(12-15%)。
  • 恶心/呕吐、抑郁/焦虑、不孕、甲状腺疾病、糖尿病和癫痫相关用药逐年增加。
  • 止吐药使用从1997-2001年的3.8%升至2014-2018年的14.8%,主要由昂丹司琼驱动。

临床怎么用

  • 临床应关注妊娠早期处方药使用的增加趋势,尤其止吐药和昂丹司琼的使用。
  • 处方时需考虑母亲和胎儿的风险与安全特征,并关注人口学亚组差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The objective of this analysis was to describe patterns of prescription medication use during pregnancy, including secular trends, with consideration of indication, and distributions of use within demographic subgroups. We conducted a descriptive secondary analysis using data from 9,755 women whose infants served as controls in two large United States case-control studies from 1997-2011 and 2014-2018. After excluding vitamin, herbal, mineral, vaccine, i.v. fluid, and topical products and over-the-counter medications, the proportion of women that reported taking at least one prescription medication in the first trimester increased over the study years, from 37% to 50% of women. The corresponding proportions increased with increasing maternal age and years of education, were highest for non-Hispanic White women (47%) and lowest for Hispanic women (24%). The most common indication for first trimester use of a medication was infection (12-15%). Increases were observed across the years for medications used for indications related to nausea/vomiting, depression/anxiety, infertility, thyroid disease, diabetes, and epilepsy. The largest relative increase in use among women was observed for medications to treat nausea/vomiting, which increased from 3.8% in the earliest years of the study (1997-2001) to 14.8% in 2014-2018, driven in large part by ondansetron use. Prescription medication use in the first trimester of pregnancy is common and increasing. Many medical conditions require treatments among pregnant women, often involving pharmacotherapy, which necessitates consideration of the risk and safety profiles for both mother and fetus.

来源:Clin Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Werler MM, Kerr SM, Ailes EC, et al. Patterns of Prescription Medication Use during the First Trimester of Pregnancy in the United States, 1997-2018. Clin Pharmacol Ther. 2023. PMID: 37356083. doi:10.1002/cpt.2981

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。